லூக்கீமியா தடுப்பு
லூக்கீமியா வருமுன் அதைத் தடுக்க முடியுமா?
பெரும்பாலான லூக்கீமியா சம்பவிப்புகளை தடுப்பதற்கு எவ்வொரு அறியப்பட்ட வழியும் இல்லை.
சில ஆபத்துக் காரணிகளை தவிர்க்கும் விதத்திலான வாழ்க்கை முறை மாற்றங்கள் மூலம் பல வகையான புற்றுநோய்களை தடுக்கமுடியும்.
அதிகளவுகளில் கதிர்வீச்சுக்கு வெளிப்படுதல் மட்டுமே, லூக்கீமியா சார்ந்து தவிர்க்கவியலும் சாத்தியமுள்ள ஒரே ஆபத்துக் காரணியாகும்; இது ஒருசில சம்பவிப்புகளிலேயே காணப்படுகிறது.
-Avoiding or reducing contact with radiation (especially to the head) and avoiding toxic chemicals associated with the oil and rubber industry, embalming chemicals, and other environmental toxins may help prevent brain cancers.
- Avoiding HIV infection is also suggested.
The American Cancer Society recommends the
following guidelines for early detection:
- All women should begin cervical cancer testing (screening) at age 21. Women aged 21 to 29, should have a Pap test every 3 years.
- Beginning at age 30, the preferred way to screen is with a Pap test combined with an HPV test every 5 years. This should continue until age 65.
- Another reasonable option for women 30 to 65 is to get tested every 3 years with just the Pap test.
Prevention of pre-cancers
Things to do to prevent pre-cancers
. Avoid being exposed to HPV
. Don't smoke
. Get vaccinated
Avoid being exposed to HPV
- Avoid sex at an early age
- Avoid multiple sexual partners
- Avoid a partner who has had many sex partners
- Avoid sex with uncircumcised males
- Men who use condoms are less likely to be infected with HPV and to pass it on to their female partners
- Not smoking is another important way to reduce the risk of cervical pre-cancer and cancer.
- Vaccines that prevent people from getting infected with HPV are now available.
-The American Cancer Society guidelines recommend that the HPV vaccine be routinely given to females aged 11 to 12 and as early as age 9 years at the discretion of doctors. The Society also recommends that catch-up vaccinations should be given to females up to age 18.
World Health Organization
WHO position paper suggests that girls within the age range of 9 through 13 years should be the primary target population for HPV immunization
www.magnahealthsolutions.com